A general framework for modeling tumor-immune system competition and immunotherapy: Mathematical analysis and biomedical inferences

Physica D: Nonlinear Phenomena

Volumn 208, Issue 3-4, 2005, Pages 220-235

  D'Onofrio, Alberto ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Cancer; Immunotherapy; Periodical forcing; Stability theory

Indexed keywords

BIOMEDICAL ENGINEERING; CELL CULTURE; COMPUTER SIMULATION; DRUG THERAPY; DYNAMICS; IMMUNOLOGY; MATHEMATICAL MODELS;

CANCER CELLS; IMMUNOTHERAPY; PERIODICAL FORCING; STABILITY THEORY;

TUMORS;

EID: 23144445934     PISSN: 01672789     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physd.2005.06.032     Document Type: Article

References (59)

1. P. Boyle, A. d'Onofrio, P. Maisonneuve, G. Severi, C. Robertson, M. Tubiana, and U. Veronesi Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about? Ann. Oncol. 14 2003 1312 1325
2. M.J. Quinn, A. d'Onofrio, B. Moeller, R. Black, C. Martinez-Garcia, H. Moeller, M. Rahu, C. Robertson, L.J. Schouten, C. La Vecchia, and P. Boyle Cancer mortality trends in the EU and acceding countries up to 2015 Ann. Oncol. 14 2003 1148 1152
3. P. Boyle, P. Autier, H. Bartelink, J. Baselga, P. Boffetta, J. Burn, H.J.G. Burns, L. Christensen, L. Denis, M. Dicato, V. Diehl, R. Doll, S. Franceschi, C.R. Gillis, N. Gray, L. Griciute, A. Hackshaw, M. Kasler, M. Kogevinas, S. Kvinnsland, C. La Vecchia, F. Levi, J.G. McVie, P. Maisonneuve, J.M. Martin-Moreno, J. Newton Bishop, F. Oleari, P. Perrin, M. Quinn, M. Richards, U. Ringborg, C. Scully, E. Siracka, H. Storm, M. Tubiana, T. Tursz, U. Veronesi, N. Wald, W. Weber, D.G. Zaridze, W. Zatonski, and H. zur Hausen European Code Against Cancer and scientific justification: third version (20kk03) Ann. Oncol. 14 2003 973 1005
4. M. Pekham, H.M. Pinedo, and U. Veronesi Oxford Textbook of Oncology 1995 Oxford Medical Publications Oxford
5. V.T. de Vito, J. Hellman, and S.A. Rosenberg Jr. Cancer: Principles and Practice of Oncology 1997 J. P. Lippincott Philadelphia
6. A. Bertuzzi, A. d'Onofrio, A. Fasano, and A. Gandolfi Regression and regrowth of tumour cords following single-dose anticancer treatment Bull. Math. Biol. 65 2003 903 931
7. T.E. Wheldon Mathematical Models in Cancer Research 1988 Hilger Publishing Boston-Philadelphia
8. A. d'Onofrio, and A. Gandolfi Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999) Math. Biosci. 191 2004 159 184
9. S.A. Agarwala (Guest Editor), New Applications of Cancer Immunotherapy, Seminars in Oncology, Special Issue 29-3, Suppl. 7, 2003.
10. I. Bleumer, E. Oosterwijk, P. de Mulder, and P.F. Mulders Immunotherapy for renal cell carcinoma Eur. Urol. 44 2003 65 75
11. C. Marras, C. Mendola, F.G. Legnani, and F. di Meco Immunotherapy and biological modifiers for the treatment of malignant brain tumors Curr. Opin. Oncol. 15 2003 204 208
12. J.M. Kaminski, J.B. Summers, M.B. Ward, M.R. Huber, and B. Minev Immunotherapy and prostate cancer Cancer Treat. Rev. 29 2004 199 209
13. N.V. Stepanova Course of the immune reaction during the development of a malignant tumor Biophysics 24 1980 917 923
14. V.A. Kuznetsov, I.A. Makalkin, M.A. Taylor, and A.S. Perelson Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis Bull. Math. Biol. 56 1994 295 321
15. F. Nani, and M.N. Oguztoreli Modelling and simulation of Rosenberg type adoptive cellular immunotherapy IMA J. Math. Appl. Med. Biol. 11 1994 107 147
16. D. Kirschner, and J.C. Panetta Modeling immunotherapy of the tumor - immune interaction J. Math. Biol. 37 1998 235 252
17. H. Ortega Un Modelo Logistico para Crecimiento Tumoral en Presencia de Celulas Asesinas Revista Mexicana de Ingenieria Biomedica 20 1999 61 67
18. N. Bellomo, and L. Preziosi Modelling and mathematical problems related to tumor evolution and its interaction with the immune system Math. Comput. Modell. 32 2000 413 452
19. F. Nani, and H.I. Freedman A mathematical model of cancer treatment by immunotherapy Math. Biosci. 163 2000 159 199
20. M. Galach Dynamics of the tumor-immune system competition: the effect of time delay Int. J. Applied Math. Comput. Sci. 13-3 2003 395 406
21. S. Szymanska Analysis of the immunotherapy models in the context of cancer dynamics Int. J. Appl. Math. Comput. Sci. 13-3 2003 407 418
22. O. Sotolongo-Costa, L. Morales-Molina, D. Rodriguez-Perez, J.C. Antonranz, and M. Chacon-Reyes Behavior of tumors under nonstationary therapy Physica D 178 2003 242 253
23. H.P. de Vladar, and J.A. Gonzalez Dynamic response of cancer under the influence of immunological activity and therapy J. Theor. Biol. 227 2004 335 348
24. N. Bellomo, A. Bellouquid, and M. Delitala Mathematical topics on the modelling complex multicellular systems and tumor immune cells competition Math. Models Methods Appl. Sci. 14 2004 1683 1733
25. J. Schmielau, and O.J. Finn Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients Cancer Res. 61 2001 4756 4760
26. D. Hart, E. Shochat, and Z. Agur The growth law of primary breast cancer as inferred from mammography screening trials data Br. J. Cancer 78 1998 382 387
27. C. Guiot, P.G. Degiorgis, P.P. Delsanto, P. Gabriele, and T.S. Deisboecke Does tumor growth follow a "universal law"? J. Theor. Biol. 225 2003 147 151
28. A. Bru, S. Albertos, J.L. Subiza, J.L. Garcia-Asenjo, and I. Bru The universal dynamics of tumor growth Biophys. J. 85 2003 2948 2961
29. B.J. Kennedy Cyclic leukocyte oscillations in chronic myelogenous leukemia during hydroxyurea therapy Blood 35 1970 751 760
30. H. Vodopick, E.M. Rupp, C.L. Edwards, F.A. Goswitz, and J.J. Beauchamp Spontaneous cyclic leukocytosis and thrombocytosis in chronic granulocytic leukemia New Engl. J. Med. 286 1972 284 290
31. H. Tsao, A.B. Cosimi, and A.J. Sober Ultra-late recurrence (15 years or longer) of cutaneous melanoma Cancer 79 1997 2361 2370
32. G. Bonadonna G. Robustelli della Cuna Medicina Oncologica 1994 Masson Milano 259 272
33. A. Kane Laird Dynamics of tumor growth Br. J. Cancer 18 1964 490 502
34. A. Kane Laird Dynamics of tumor growth: comparison of growth rates and extrapolation of growth curve to one cell Br. J. Cancer 19 1965 278 290
35. I.D. Bassukas Gompertzian re-evaluation of the growth patterns of transplantable mammary tumours in sialoadenectomized mice Cell Prolif. 27 1994 201 211
36. N. Olea, M. Villalobos, M.I. Nunez, J. Elvira, and J.M. Ruiz de Almodovar Evaluation of the growth rate of MCF-7 breast cancer multicellular spheroids using three mathematical models Cell Prolif. 27 1994 213 227
37. A.M. Parfitt Gompertzian growth curves in parathyroid tumours: further evidence for the set-point hypothesis Cell Prolif. 30 1994 341 649
38. K. Rygaard, and M. Spang-Thomsen Quantitation and Gompertzian analysis of tumor growth Breast Cancer Res. Treat. 46 1997 303 312
39. A.M. Ballangrud, W.H. Yang, A. Dnistrian, N.L. Lampen, and G. Sgourous Growth anc characterization of LNCaP prostate cancer Clin. Cancer Res. 5 1999 3167s 3171s
40. D.A. Cameron The relative importance of proliferation and cell death in breast cancer growth and response to tamoxifen Eur. J. Cancer 37 2001 1545 1553
41. M.A.A. Castro, F. Klamt, V.A. Grieneisen, I. Grivicich, and J.C.F. Moreira Gompertzian growth pattern correlated with phenotypic organization of colon carcinoma, malignant glioma and non-small cell lung carcinoma cell lines Cell Prolif. 36 2003 65 73
42. M. Gyllenberg, and G. Webb Quiescence as an explanation of Gompertzian tumor growth, Growth Dev. Aging 53 1989 25 33
43. C. Calderon, and T. Kwembe Modeling Tumor Growth Math. Biosci. 103 1991 97 114
44. E.K. Afenya, and C.P. Calderon Diverse ideas on the growth kinetics of disseminated cancer cells Bull. Math. Biol. 62 2000 527 542
45. E.K. Afenya, and C.P. Calderon Growth kinetics of cancer cells prior to detection and treatment: an alternative view Discrete Cont. Dynam. Syst. B 5 2004 25 28
46. M. Molski and J. Konarski, Coherent states of Gompertzian growth, Phys. Rev. E, 68 Art. No. 021916 Part, 1 Augest 2003.
47. P. Waliszewski, and J. Konarski The Gompertzian curve reveals fractal properties of tumor growth Chaos Solitons Fractals 16 2003 665 674
48. P. Castorina and D. Zappala', Tumor Gompertzian growth by cellular energetic balance, arXiv:q-bio.CB/0407018 v2, 21 December 2004.
49. P. Castorina and D. Zappala', Energetic Model of Tumor Growth, arXiv:q-bio.TO/0412040 v1, 22 December 2004.
50. M. Marusic, Z. Bajzer, J.P. Freyer, and S. Vuk-Pavlovic Analysis of growth of multicellular tumour spheroids by mathematical models Cell Prolif. 27 1994 73 94
51. I.M. van Leeuwen, and C. Zonneveld From exposure to effect: a comparison of modeling approaches to chemical carcinogenesis Mutat. Res. 489 2001 17 45
52. R. Demicheli, R. Foroni, A. Ingrosso, G. Pratesi, C. Soranzo, and M. Tortoreto An Exponential-Gompertzian description of LoVo cell tumor growth from in vivo and in vitro data Cancer Res. 49 1989 6543 6546
53. V.G. Vaydia, and F.J. Alexandro Jr. Evaluation of some mathematical models for tumor growth Int. J. Biomed. Comput. 13 1982 19 36
54. G.G. Steel Groth Kinetics of Tumours 1977 Clarendon Press Oxford
55. S. Piantadosi A Model of Growth with first-order birth and death rates Comput. Biomed. Res. 18 1985 220 232
56. H. Thieme Mathematics in Population Biology 2003 Princeton University Press Princeton
57. G.P. Dunn, A.T. Bruce, H. Ikeda, L.J. Old, and R.D. Schreiber Cancer immunoediting: from immunosurveillance to tumor escape Nature Immunol. 3 2002 991 997
58. G.P. Dunn, L.J. Old, and R.D. Schreiber The three ES of cancer immunoediting Ann. Rev. Immunol. 22 2004 322 360
59. F.M.O. Al-Dwery, D. Guirado, A.M. Lallena, and V. Pedraza Effect of tumour control of time interval between surgery and postoperative radiotherapy: an empirical approach using Monte Carlo simulation Phys. Med. Biol. 49 2004 2827 2839